Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.20 -0.21 (-6.14%)
As of: Oct 21, 2026 · 3:59 PM EDT

Apimeds Pharmaceuticals US (APUS) EPS (Basic) (2024 - 2026)

Updated

Apimeds Pharmaceuticals US (APUS) reported EPS (Basic) of -$11.77 for Q2 2026, compared with -$2.57 a year earlier.

Analysis

Apimeds Pharmaceuticals US (APUS) EPS (Basic) (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Apimeds Pharmaceuticals US's EPS (Basic) came in at -$15.04; for FY2025, it came in at -$5.51.

  • By year, EPS (Basic) came in at -$1.76 in FY2024 and -$1.69 in FY2023.
  • The Q2 2026 figure ranks as the lowest quarterly EPS (Basic) in data going back to Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.95
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 2.30
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.04
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -0.54
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.68
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.62
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 4.40
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -8.44
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -0.04
10 Apimeds Pharmaceuticals US 5.44 Mn -14.20 Mn - -11.77
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.77
Dec 31, 2025 -1.06
Sep 30, 2025 -1.42
Jun 30, 2025 -2.57
Mar 31, 2025 -0.51
Dec 31, 2024 -0.39
Sep 30, 2024 -0.42
Jun 30, 2024 -0.57
Mar 31, 2024 -0.38
API Access

Apimeds Pharmaceuticals US EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=APUS&period=max&api_key=YOUR_API_KEY